MANUFACTURING PROCESS

Safety in Every Step
From Donor Screening to the Final Product

Koāte-DVI is made from donated human plasma. Today, plasma-derived therapies are effectively used to treat many life-threatening conditions. All plasma-derived therapies undergo viral removal and/or inactivation steps during production.These steps are effective in helping to eliminate potential risks from infectious agents.1–3

Koāte-DVI is made from human plasma. Products made from human plasma may contain infectious agents, such as viruses, and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent that can cause disease. There is also the possibility that unknown infectious agents may be present in such products.

The manufacturing process for Koāte-DVI involves multiple steps focused on viral safety, including 2 independent steps to effectively eliminate viruses.

In total, manufacturing Koāte-DVI involves multiple steps that are focused on safety.

Watch Manufacturing Koate-DVI: Safety in Every Step

Learn more about how Koāte-DVI is made with safety in every step.

Commitment to Safety

There has never been a case of virus transmission with Koāte-DVI. Koāte-DVI is committed to the safe manufacture of all products, now and in the future. Click here for more information about Talecris’ commitment to safety.

 

References: 1. Data on file. Talecris Biotherapeutics, Inc., Research Triangle Park, NC. 2. Plasma Protein Therapeutics Association. Saving & Improving Lives: Plasma Protein Therapies. 3. National Heart Lung and Blood Institute. Hemophilia. http://www.nhlbi.nih.gov/health/dci/Diseases/hemophilia/hemophilia_all.html.